Enliven Therapeutics, Inc. (ELVN)
44.69
+1.00
(+2.29%)
USD |
NASDAQ |
Oct 28, 13:45
Enliven Therapeutics Price : 44.69 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 41.80 | 44.37 | 41.52 | 43.69 | 3.308M |
| Oct 26, 2026 | 41.58 | 42.18 | 40.90 | 41.49 | 2.323M |
| Oct 23, 2026 | 41.49 | 41.64 | 40.82 | 41.52 | 2.299M |
| Oct 22, 2026 | 41.55 | 42.87 | 41.06 | 41.93 | 2.325M |
| Oct 21, 2026 | 41.76 | 42.92 | 41.58 | 41.82 | 2.053M |
| Oct 20, 2026 | 38.86 | 41.36 | 38.41 | 41.25 | 1.938M |
| Oct 19, 2026 | 38.01 | 38.83 | 37.50 | 38.70 | 1.312M |
| Oct 16, 2026 | 39.33 | 39.46 | 36.96 | 37.32 | 1.188M |
| Oct 15, 2026 | 39.48 | 40.29 | 38.49 | 39.33 | 2.054M |
| Oct 14, 2026 | 38.99 | 39.95 | 38.51 | 39.28 | 1.217M |
| Oct 13, 2026 | 40.56 | 40.99 | 39.27 | 39.49 | 847875.0 |
| Oct 12, 2026 | 40.67 | 41.41 | 40.50 | 40.84 | 579824.0 |
| Oct 09, 2026 | 41.00 | 42.06 | 40.29 | 40.98 | 1.003M |
| Oct 08, 2026 | 40.90 | 40.90 | 39.25 | 40.63 | 1.652M |
| Oct 07, 2026 | 41.62 | 42.38 | 41.04 | 41.36 | 1.461M |
| Oct 06, 2026 | 45.38 | 45.60 | 41.22 | 42.39 | 2.333M |
| Oct 05, 2026 | 46.94 | 46.94 | 45.23 | 45.47 | 821505.0 |
| Oct 02, 2026 | 47.38 | 47.43 | 45.92 | 46.97 | 1.123M |
| Oct 01, 2026 | 46.29 | 47.22 | 45.70 | 46.21 | 944890.0 |
| Sep 30, 2026 | 46.98 | 46.98 | 45.47 | 45.84 | 800171.0 |
| Sep 29, 2026 | 46.01 | 46.87 | 45.40 | 46.51 | 1.256M |
| Sep 28, 2026 | 44.38 | 46.90 | 44.19 | 46.01 | 1.285M |
| Sep 25, 2026 | 45.54 | 45.77 | 44.18 | 44.75 | 963790.0 |
| Sep 24, 2026 | 45.90 | 46.52 | 44.81 | 45.17 | 749360.0 |
| Sep 23, 2026 | 47.84 | 48.03 | 45.66 | 46.09 | 1.551M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Definium Therapeutics, Inc. | 38.04 |
| Cocrystal Pharma, Inc. | 0.99 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.66 |
| Fulcrum Therapeutics, Inc. | 3.725 |
Price Related Metrics
| Price to Book Value | 3.657 |
| Earnings Yield | -3.73% |
| Market Cap | 3.274B |